New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
Jensen, who as CEO led Nasdaq-listed biotech Allarity Therapeutics' refocusing around a single lead asset, cites Valion's rare combination of...
The 800-Pound Gorilla in the Room: DEA Now Confirms Marijuana Production Quotas Are Coming